Skip to main content
bioMérieux S.A. (EPA:BIM)
France flag France · Delayed Price · Currency is EUR
104.80
+0.60 (0.58%)
At close: Dec 5, 2025

bioMérieux Revenue

bioMérieux had revenue of 2.04B EUR in the half year ending June 30, 2025, with 15.46% growth. This brings the company's revenue in the last twelve months to 4.12B, up 8.28% year-over-year. In the year 2024, bioMérieux had annual revenue of 3.98B with 8.31% growth.

Revenue (ttm)
4.12B
Revenue Growth
+8.28%
P/S Ratio
3.00
Revenue / Employee
285.23K
Employees
14,754
Market Cap
12.37B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.98B305.20M8.31%
Dec 31, 20233.67B85.60M2.39%
Dec 31, 20223.59B212.90M6.31%
Dec 31, 20213.38B258.00M8.27%
Dec 31, 20203.12B443.40M16.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
EssilorLuxottica Société anonyme 27.24B
Sanofi 45.93B
Sartorius Stedim Biotech 2.95B
Eurofins Scientific SE 7.14B
Ipsen 3.76B
ABIVAX Société Anonyme 6.02M
Virbac 1.43B
emeis Société anonyme 5.77B
Revenue Rankings

bioMérieux News

More News